HoJin Shin

ORCID: 0000-0002-2032-6134

MedicineMathematicsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results”.

Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results

Clinical Pharmacology & Therapeutics(2023)10.1002/cpt.2983

N/A

0.165DataRank · unranked

2 citations

Shirley Wang, Dae Hyun Kim, Ethan M. Alt, Mufaddal Mahesri, Lily G. Bessette +3 more

Cost-effectiveness of endovascular versus open surgery for chronic limb-threatening ischemia

medRxiv(2025)10.1101/2025.09.22.25336403

N/A

0DataRank · unranked

0 citations

Mehdi Najafzadeh, Mufaddal Mahesri, HoJin Shin, Philip P. Goodney, Michael S. Conte +12 more